PRL and breast carcinoma: Having demonstrated a molecular antagonism between PRL/PRLR pathway and YAP-CCN2 pathway in mammary and breast cancer cells, we next sought to determine the clinical impact of this antagonism regarding breast cancer prognosis and potential therapeutic value.